Skip to main content

Oligometastasis clinical trials at UCSD
1 research study open to eligible people

  • Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

    open to eligible people ages 18 years and up

    This phase III trial compares nephrectomy (surgery to remove a kidney or part of a kidney) with or without nivolumab in treating patients with kidney cancer that is limited to a certain part of the body (localized). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed, and after nephrectomy to increase survival. It is not yet known whether nivolumab and nephrectomy is more effective than nephrectomy alone in treating patients with kidney cancer.

    La Jolla, California and other locations

Last updated: